These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 9437812)

  • 1. Lies, damn lies, and reference intervals (or hysterical control values for clinical pathology data).
    Hall RL
    Toxicol Pathol; 1997; 25(6):647-9; discussion 650-1. PubMed ID: 9437812
    [No Abstract]   [Full Text] [Related]  

  • 2. Historical ranges: obfuscating perambulators of statistical graffiti or useful tools?
    Rock MT; Khan KN
    Toxicol Pathol; 1997; 25(6):651-2. PubMed ID: 9437813
    [No Abstract]   [Full Text] [Related]  

  • 3. Harmonization of animal clinical pathology testing in toxicity and safety studies. The Joint Scientific Committee for International Harmonization of Clinical Pathology Testing.
    Weingand K; Brown G; Hall R; Davies D; Gossett K; Neptun D; Waner T; Matsuzawa T; Salemink P; Froelke W; Provost JP; Dal Negro G; Batchelor J; Nomura M; Groetsch H; Boink A; Kimball J; Woodman D; York M; Fabianson-Johnson E; Lupart M; Melloni E
    Fundam Appl Toxicol; 1996 Feb; 29(2):198-201. PubMed ID: 8742316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pathology testing in toxicity studies.
    Brown G
    Toxicol Pathol; 1992; 20(4):672-3. PubMed ID: 1308629
    [No Abstract]   [Full Text] [Related]  

  • 5. Documentation of pathology peer review. Position of the Society of Toxicologic Pathologists.
    Toxicol Pathol; 1997; 25(6):655. PubMed ID: 9437815
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical pathology in the National Toxicology Program.
    Thompson MB
    Toxicol Pathol; 1992; 20(3 Pt 2):484-8; discussion 488-9. PubMed ID: 1296277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. International Workshop on Clinical Pathology Testing in Preclinical Safety Assessment. Proceedings. Washington, D.C., July 27, 1991.
    Toxicol Pathol; 1992; 20(3 Pt 2):469-543. PubMed ID: 1363584
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical pathology for preclinical safety assessment: current global guidelines.
    Hall RL
    Toxicol Pathol; 1992; 20(3 Pt 2):472-6. PubMed ID: 1296274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced histopathology of the immune system: a review and update.
    Elmore SA
    Toxicol Pathol; 2012; 40(2):148-56. PubMed ID: 22089843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference Method and Reference Material Are Necessary Tools to Reveal the Variability of Cystatin C Assays.
    Bargnoux AS; Kuster N; Delatour V; Delanaye P; González-Antuña A; Cristol JP; Piéroni L; Cavalier E;
    Arch Pathol Lab Med; 2016 Feb; 140(2):117-8. PubMed ID: 26910214
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymology in preclinical safety evaluation.
    Davies DT
    Toxicol Pathol; 1992; 20(3 Pt 2):501-5. PubMed ID: 1296279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pathology testing recommendations for nonclinical toxicity and safety studies.
    Evans GO
    Toxicol Pathol; 1993; 21(5):513-4. PubMed ID: 8115827
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigative toxicologic pathology in safety assessment--a commentary.
    Farber E
    Toxicol Pathol; 1997; 25(6):660-1. PubMed ID: 9437817
    [No Abstract]   [Full Text] [Related]  

  • 14. Automated bone marrow analysis in rats--a change in paradigm in toxicologic clinical pathology?
    von Beust B
    Vet Clin Pathol; 2014 Jun; 43(2):121-2. PubMed ID: 24894068
    [No Abstract]   [Full Text] [Related]  

  • 15. Response to International recommendations for training future toxicologic pathologists participating in regulatory-type, nonclinical toxicity studies by Bolon et. al.
    Tripathi NK
    Toxicol Pathol; 2010 Dec; 38(7):1167. PubMed ID: 21248324
    [No Abstract]   [Full Text] [Related]  

  • 16. [Outline of histomorphometric principles in pathomorphologic examination].
    Zieliński KW
    Pol J Pathol; 1994; 45(4 Suppl):1-94. PubMed ID: 7866750
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical pathology: preanalytical variation in preclinical safety assessment studies--effect on predictive value of analyte tests.
    Riley JH
    Toxicol Pathol; 1992; 20(3 Pt 2):490-500. PubMed ID: 1296278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical aspects of reference values in clinical pathology.
    Harris EK
    Prog Clin Pathol; 1981; 8():45-66. PubMed ID: 7029627
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulatory forum opinion piece: thresholds in toxicologic pathology.
    Long GG; Hardisty JF
    Toxicol Pathol; 2012 Oct; 40(7):1079-81. PubMed ID: 22585940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scientific and Regulatory Policy Committee Review: Review of the Organisation for Economic Co-operation and Development (OECD) Guidance on the GLP Requirements for Peer Review of Histopathology.
    Fikes JD; Patrick DJ; Francke S; Frazier KS; Reindel JF; Romeike A; Spaet RH; Tomlinson L; Schafer KA;
    Toxicol Pathol; 2015 Oct; 43(7):907-14. PubMed ID: 26208968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.